How valuable is FeNo Testing in the Diagnosis and Management of Asthma ?
14th October 2021 – 19:00 – 20:00
Come and join us for our FeNO webinar to understand more about this hot topic for Primary Care.
Did you know
- Over 5.4 million people in the UK are diagnosed with asthma. 30% of these patients are suspected to have been misdiagnosed.
- FeNO testing is a simple, quick, point of care test that is used to aid the diagnosis of asthma and is also used in the ongoing management of patients
- FeNO is a measure of nitric oxide in exhaled breath and gives an indication of the level of inflammation in the lungs and aids decisions about individualised patient management
- FeNO testing is recommended in all asthma clinical guidelines and is backed by NHS England
Learning Outcomes
- Awareness of the importance of identifying phenotypes and endotypes and the use of biomarkers
- Clarify the use objective tests in asthma assessment
- Become familiar with current clinical guidelines and evidence for the use of FeNO and spirometry in primary care and their interpretation
- Observe practical sessions to demonstrate the correct use of spirometry and FeNO testing Identify priority patients for review
Please visit our website www.dovetail-medical-events.co.uk to book your place.
